Research Progress in Oxygen Carrier Design and Application-Reference-Cited by-同舟云学术

Research Progress in Oxygen Carrier Design and Application

Published:2023-08-14 Issue:9 Volume:20 Page:4373-4386
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Ye Qingsong¹,Zheng Deyuan¹,Chen Kaiyuan¹,Wu Jinhui¹²^ORCID

Affiliation:

1. State Key Laboratory of Pharmaceutical Biotechnology, Chemistry and Biomedicine Innovation Center, Medical School of Nanjing University, Nanjing 210093, China

2. Jiangsu Key Laboratory for Nano Technology, Nanjing University, 22 Hankou Road, Nanjing 210093, China

Funder

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.3c00289

Reference113 articles.

1. Hemorrhagic Shock

2. The impact of hypoxia on immune state in cancer

3. Cerebral ischemia and neuroregeneration

4. Effects of high altitude on renal physiology and kidney diseases

5. Artificial oxygen carriers and red blood cell substitutes: A historic overview and recent developments toward military and clinical relevance

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficient conversion of hemoglobin to a non-vasoactive oxygen carrier by site-specific cross-linking with azido acyl methyl phosphates followed by bio-orthogonal CuAAC with a bis-alkyne;Bioorganic Chemistry;2024-08

2. A mesoporous theranostic platform for ultrasound and photoacoustic dual imaging-guided photothermal and enhanced starvation therapy for cancer;Acta Biomaterialia;2024-07

3. An ex vivo method to evaluate vasoactivity induced by hemoglobin-based oxygen carriers in resistance vessels;Frontiers in Bioengineering and Biotechnology;2024-06-28

4. Novel perfluorocarbon-based oxygenation therapy alleviates Post-SAH hypoxic brain injury by inhibiting HIF-1α;Free Radical Biology and Medicine;2024-03

5. Mitochondrial Disruption Nanosystem Simultaneously Depressed Programmed Death Ligand-1 and Transforming Growth Factor-β to Overcome Photodynamic Immunotherapy Resistance;ACS Nano;2024-01-16